ArticleMedicina (Kaunas, Lithuania)2026
Alterations in PD-L1
Kerim Bora Yilmaz, Ece Tavukcuoglu, Hamdullah Yanik, Pelin Seçken, Ertugrul Celik, Sumeyra Guler, Mehmet Mert Hidiroglu, Ibrahim Burak Bahcecioglu, Ismail Erturk, Mehmet Ali Gulcelik and 2 more
Abstract read
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Kerim Bora YilmazDepartment of Medical and Surgical Research, Institute of Health Sciences, Hacettepe University, 06800 Ankara, Turkey.ORCID 0000-0002-5514-4103 Ece TavukcuogluDepartment of Basic Oncology, Cancer Institute, Hacettepe University, 06800 Ankara, Turkey.ORCID 0000-0003-3344-468X Hamdullah YanikDepartment of Basic Oncology, Cancer Institute, Hacettepe University, 06800 Ankara, Turkey.ORCID 0000-0002-1066-552X Pelin SeçkenDepartment of Pathology, Gulhane Training and Research Hospital, University of Health Sciences, 06010 Ankara, Turkey.ORCID 0009-0007-5751-7907 Ertugrul CelikDepartment of Pathology, Gulhane Training and Research Hospital, University of Health Sciences, 06010 Ankara, Turkey.ORCID 0000-0002-9982-192X Sumeyra GulerDepartment of Surgical Oncology, Gulhane Training and Research Hospital, University of Health Sciences, 06010 Ankara, Turkey.ORCID 0000-0001-5069-1872 Mehmet Mert HidirogluDepartment of General Surgery, Gulhane Training and Research Hospital, University of Health Sciences, 06010 Ankara, Turkey.ORCID 0009-0009-1137-8803 Ibrahim Burak BahceciogluDepartment of Surgical Oncology, Gulhane Training and Research Hospital, University of Health Sciences, 06010 Ankara, Turkey.ORCID 0000-0001-9417-3866 Ismail ErturkDepartment of Medical Oncology, Gulhane Training and Research Hospital, University of Health Sciences, 06010 Ankara, Turkey.
Mehmet Ali GulcelikDepartment of Surgical Oncology, Gulhane Training and Research Hospital, University of Health Sciences, 06010 Ankara, Turkey.ORCID 0000-0002-8967-7303 Derya KarakocDepartment of Medical and Surgical Research, Institute of Health Sciences, Hacettepe University, 06800 Ankara, Turkey.
Gunes EsendagliDepartment of Medical and Surgical Research, Institute of Health Sciences, Hacettepe University, 06800 Ankara, Turkey.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antibodies, Monoclonal, HumanizedB7-H1 AntigenMyeloid CellsPaclitaxelTriple Negative Breast NeoplasmsAnimalsDisease Models, AnimalFemaleHumansImmune Checkpoint InhibitorsMiceTumor MicroenvironmentAntibodies, Monoclonal, HumanizedatezolizumabB7-H1 AntigenImmune Checkpoint InhibitorsPaclitaxelatezolizumabcombination therapyimmune checkpoint inhibitorsmetastasispaclitaxeltreatment responsetriple-negative breast cancertumor immune microenvironment
Identifiers
PMID41901681
PMCPMC13028344
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390